Computational Study of E-Compound from the Vitex Family as Novel Potential Anti-Alzheimer Agents: An in Silico Study
Main Article Content
Abstract
The degenerative disease of memory that most attacks the frontal lobe is Alzheimer's. Therapy for Alzheimer's is mostly done by targeting an increase in the amount of acetylcholinesterase in the synapse cleft by inhibiting the enzyme acetylcholinesterase. The purpose of this study is to conduct a comparative study of vitexifolin E compounds from the vitexium plant family with donepezil to obtain more precise and targeted drug candidates in Alzheimer's therapy. The results showed that donepezil compounds have a more active probability (0.53) of being carcinogenic compared to vitexifolin E with the web-based application Protox II. Tests with in silico studies found that the hydrogen bonding results of vitexifolin E had values close to those of donepezil drugs, as well as RMSD results with receptors between donepezil and vitexifolin E (1,781; 1,281) and free energy obtained (-6.9; -7.8). Based on these results, it can be concluded that vitexifolin E compounds can have good enough potential to be developed in implementing the treatment of Alzheimer's disease therapy.
Article Details
References
smith, m. a. alzheimer disease. international review of neurobiology 42, 1–54 (1998).
knopman, d. s. et al. alzheimer disease. nature reviews disease primers 7, 33 (2021).
seltzer, b. donepezil: an update. expert opinion on pharmacotherapy 8, 1011–1023 (2007).
birks, j. s. & harvey, r. j. donepezil for dementia due to alzheimer’s disease. cochrane database of systematic reviews (2018).
ahmad, b. et al. anti‐inflammatory and enzyme inhibitory activities of a crude extract and a pterocarpan isolated from the aerial parts of vitex agnus‐castus. biotechnology journal 5, 1207–1215 (2010).
akhtar, m., padmini, s., prabodh, s., alok, s. & alok, m. comparative in-vitro evaluation of vitex leucoxylon linn. bark for antioxidant activity. international journal of pharmaceutical sciences and research (ijpsr) 1, 27–33 (2010).
bello, o. m., ogbesejana, a. b., adetunji, c. o. & oguntoye, s. o. flavonoids isolated from vitex grandifolia, an underutilized vegetable, exert monoamine a & b inhibitory and anti-inflammatory effects and their structure-activity relationship. turkish journal of pharmaceutical sciences 16, 437 (2019).
hamood, h. m. & al-zubaidy, a. a. neuroprotective effects of vitex agnus castus extract in rats’ model of alzheimer’s disease. eurasian journal of biosciences 14, (2020).
jan, h. et al. plant-based synthesis of zinc oxide nanoparticles (zno-nps) using aqueous leaf extract of aquilegia pubiflora: their antiproliferative activity against hepg2 cells inducing reactive oxygen species and other in vitro properties. oxidative medicine and cellular longevity 2021, (2021).
shen, t., wang, y., zhu, z., wang, x. & tian, t. lignans and terpenoids from the fruits of vitex kwangsiensia and their inhibitory activity on nitric oxide production in macrophages. natural product communications 14, 1934578x19848178 (2019).
ababutain, i. m. & alghamdi, a. i. in vitro anticandidal activity and gas chromatography-mass spectrometry (gc-ms) screening of vitex agnus-castus leaf extracts. peerj 9, e10561 (2021).
kavaz, a., işık, m., dikici, e. & yüksel, m. anticholinergic, antioxidant, and antibacterial properties of vitex agnus‐castus l. seed extract: assessment of its phenolic content by lc/ms/ms. chemistry & biodiversity 19, e202200143 (2022).
syahputra, h. d., nasri, n. & kaban, v. e. pengujian potensi aktivitas antibakteri dari daun cep-cepan (saurauia cauliflora dc.) dalam formulasi sediaan gel terhadap propionibacterium acnes. herbal medicine journal 5, 28–32 (2022).
ono, m., yanaka, t., yamamoto, m., ito, y. & nohara, t. new diterpenes and norditerpenes from the fruits of vitex r otundifolia. journal of natural products 65, 537–541 (2002).
azizul, n. h. et al. the coastal medicinal plant vitex rotundifolia: a mini-review on its bioactive compounds and pharmacological activity. tradit. med. res 6, (2021).
islamie, r. et al. construction of network pharmacology-based approach and potential mechanism from major components of coriander sativum l. against covid-19. pharmacia 69, (2022).
banerjee, p. & ulker, o. c. combinative ex vivo studies and in silico models protox-ii for investigating the toxicity of chemicals used mainly in cosmetic products. toxicology mechanisms and methods 32, 542–548 (2022).
haider, m. s. et al. chemical characterization and evaluation of the neuroprotective potential of indigofera sessiliflora through in-silico studies and behavioral tests in scopolamine-induced memory compromised rats. saudi journal of biological sciences 28, 4384–4398 (2021).
ahmad, m. donepezil: a review of the recent structural modifications and their impact on anti-alzheimer activity. brazilian journal of pharmaceutical sciences 56, e18325 (2020).
boschert, s. diabetes found in one-third of residents. caring for the ages 9, 23 (2008).
meier-davis, s. r. et al. dried blood spot analysis of donepezil in support of a glp 3-month dose-range finding study in rats. international journal of toxicology 31, 337–347 (2012).
pagadala, n. s., syed, k. & tuszynski, j. software for molecular docking: a review. biophysical reviews 9, 91–102 (2017).
syahputra, h. d., masfria, m., hasibuan, p. a. z. & iksen, i. in silico docking studies of phytosterol compounds selected from ficus religiosa as potential chemopreventive agent.
davis, a. m. & teague, s. j. hydrogen bonding, hydrophobic interactions, and failure of the rigid receptor hypothesis. angewandte chemie international edition 38, 736–749 (1999).
weinhold, f. & klein, r. a. what is a hydrogen bond? mutually consistent theoretical and experimental criteria for characterizing h-bonding interactions. molecular physics 110, 565–579 (2012).
fu, y. et al. identification of novel inhibitors of p-hydroxyphenylpyruvate dioxygenase using receptor-based virtual screening. journal of the taiwan institute of chemical engineers 103, 33–43 (2019).